Sexual Health and Aging: A Whole-Body Longevity Guide

Sexual function changes across adulthood, but common does not mean that every change requires treatment. Frequency and response vary widely. Distress, pain, loss of function, safety concerns, or a persistent change from your usual experience are practical reasons to seek care.

What Sexual Function Is Made Of

A clinician usually asks about several overlapping areas. They are prompts for a history, not a private taxonomy or a self-test.

• Desire

  Interest may arise spontaneously or after intimacy and arousal begin. A change matters when it causes distress or difficulty.
• Arousal and orgasm

  Ask whether physical response, lubrication, sensation, or orgasm has changed and whether the change is situational or consistent.
• Erections and blood flow

  New or worsening erectile dysfunction can have vascular, neurologic, medication-related, hormonal, or psychological causes.
• Pain and genital comfort

  Dryness, burning, pelvic-floor problems, infection, skin conditions, and GSM can make sexual activity painful.
• Health and context

  Hormones, medicines, sleep, mood, stress, illness, safety, and relationship context can affect every other area.

Responsive desire is one model developed to describe women whose interest begins after intimacy or arousal ¹. It is not a universal description of women or of all sexual response. In a United States survey, 43.1% of women reported a sexual problem, while 12.0% reported one that caused distress ². Among women ages 45 to 64, 14.8% reported a distressing problem.

After menopause, dryness, burning, pain, and some urinary symptoms may be caused by genitourinary syndrome of menopause (GSM) ³. Estimates range from 27% to 84% of postmenopausal women because studies use different definitions ⁴. These symptoms require evaluation because GSM is not the only possible cause.

No single category explains sexual function. The same complaint can have different causes in two people and several causes in one person.

Is low sex drive a hormone problem?

Sometimes. In men, testosterone treatment is supported only when relevant symptoms occur with consistently low morning levels. After menopause, pain, sleep, mood, medications, and relationship context may matter as much as hormones. A history and targeted evaluation are more useful than assuming one hormone is responsible.

What People Do About It, From First Steps to Clinical Care

Treatment should match the diagnosis or symptom being addressed. The main categories solve different problems.

For mild GSM symptoms, first-line options include lubricants used during sexual activity and vaginal moisturizers used regularly ⁴. Persistent pain, bleeding, discharge, skin changes, or urinary symptoms should be evaluated rather than managed indefinitely without a diagnosis.

For erectile dysfunction, common first-line medicines are PDE-5 inhibitors such as sildenafil (Viagra) and tadalafil (Cialis) ⁷. They must not be combined with nitrate medicines because the combination can cause a dangerous blood-pressure drop. Low-dose vaginal estrogen and vaginal DHEA treat GSM locally. Ospemifene is an oral systemic option with boxed-warning and contraindication information ⁴.

Testosterone can improve sexual function in men with symptoms and confirmed low levels ¹², ¹³. It is not a general erectile or energy treatment. Bremelanotide (Vyleesi) is approved only for selected premenopausal women with acquired, generalized HSDD ⁵. It temporarily raises blood pressure and is contraindicated with uncontrolled hypertension or known cardiovascular disease. Our treatment comparison explains its narrow indication.

Low-intensity extracorporeal shockwave therapy (Li-ESWT) for ED has shown improvement in pooled trials, but protocols and appropriate candidates remain unsettled ⁶. It is not FDA-approved for ED. The American Urological Association calls it investigational and recommends restricting it to research settings ⁷.

An erection medicine will not directly restore desire. Local GSM treatment can improve sexual experience by relieving pain but is not a direct desire treatment. Medication changes, counseling, pelvic-floor therapy, or treatment of another condition may be appropriate when those factors drive the problem.

Sexual Function as a Health Signal

The best-supported cardiovascular association concerns ED in men. It should not be generalized to low desire, pain, orgasm changes, or sexual function as a whole.

In pooled prospective cohorts, men with ED had a 48% higher relative rate of cardiovascular disease than men without ED ⁸. Rates were also higher for coronary heart disease, stroke, and all-cause mortality. A separate meta-analysis found a similar pattern ⁹. These are group-level observational associations. ED is a marker, not proof that cardiovascular disease is present or that ED caused it.

The Princeton IV consensus recommends cardiovascular-risk assessment for men with ED ¹⁰. In selected men whose risk remains uncertain, coronary-artery calcium scoring may refine that assessment. It is not a routine test for every sexual-health concern.

An ED appointment can identify untreated blood pressure, cholesterol, blood sugar, smoking, medication, or sleep concerns. Treating those risks is worthwhile even if the erectile problem has another cause. Evidence has not shown that ED treatment extends life.

Low desire, pain, or another sexual concern may still justify medical care. It simply should not be presented as a cardiovascular warning without evidence.

How Strong the Evidence Is for Each Treatment

Evidence and restrictions differ by treatment. This table is a navigation aid, not a prescribing guide.

Treatment comparisons do not replace product-specific safety review. The complete decisions about testosterone therapy and menopause hormone therapy include diagnosis, monitoring, and risk counseling.

None of the treatments reviewed here has an established lifespan benefit. One cohort of 918 middle-aged men associated higher orgasm frequency with lower mortality ¹⁴. Healthier men may have more sex, so the study cannot establish cause or a treatment benefit. The supported goal is better sexual function and appropriate evaluation of underlying health concerns.

Raising It With a Clinician, and What a Workup Can Cover

Begin with a specific description: what changed, when it changed, whether it is consistent, and how it affects you. Include pain, bleeding, urinary symptoms, and any safety or consent concerns.

The clinician should review medicines and substances, medical conditions, menopause or reproductive history, sleep, mood, and relationship context. Examination and testing then follow the history. There is no universal sexual-health blood panel.

For ED, cardiovascular-risk assessment is recommended, and selected men may benefit from coronary-artery calcium scoring ¹⁰. For suspected GSM, the evaluation should exclude other causes before treatment ⁴. Testosterone testing in men is appropriate when symptoms support it, followed by repeat morning confirmation if low ¹². Our blood-biomarkers guide explains common tests, but the history determines which are relevant.

Useful opening statements include: “My erections have become less reliable over the past year, and I want an ED and cardiovascular-risk evaluation.” Another is: “Sex has been painful since menopause, and lubricants are no longer enough.” Specific language helps the visit address the concern directly.

Primary care can start most evaluations. Urology, gynecology, sexual medicine, pelvic-floor therapy, cardiology, endocrinology, or mental-health care may be appropriate depending on the findings.

Where Sexual Health Fits in a Longevity Plan

Sexual health belongs in routine health care because it affects quality of life, relationships, comfort, and function. It can also reveal medication effects or untreated health conditions.

The strongest preventive link is specific: ED in men is associated with cardiovascular risk. Other sexual concerns deserve evaluation for their own medical and quality-of-life effects, not because they have been proven to predict longevity.

Match treatment to the cause, review progress, and reconsider the diagnosis when treatment does not help. No sexual-health treatment has been shown to add years to life.

Look for care that includes a complete history, appropriate examination, targeted testing, product-specific safety counseling, and follow-up. Telehealth can be useful, but it should provide the same diagnostic and monitoring standards as in-person care.